Grifols acquires the remaining 49% of MedKeeper for 60.2 million dollars
ABC Madrid Updated:11/09/2020 20: 51h save Related news Grifols announced this Monday in a statement…
grifols
The CNMV prohibits bearish bets to curb panic on the Spanish stock market | Markets
The CNMV takes the lead in attacking the coronavirus and uses one of the aces…
Grifols grows 1.5% in 2018 due to the growth of sales | Economy
Grifols, the Catalan multinational dedicated to homoderivatives, won 596.6 million euros in 2018, 1.5% more…
Grifols sells its Haema and Biotest plasma suppliers for 469 million | Economy
The Spanish multinational of blood products Grifols has sold two of its companies, the US…
Grifols negotiates entering China through the merger of its US subsidiary with a local firm | Economy
Grifols, the Spanish pharmaceutical company specializing in blood products, has begun talks with the Chinese…
Grifols seeks the philosopher's stone to cure Alzheimer's | Economy
The publication of clinical trial results usually causes bursatile earthquakess among pharmaceutical companies. This has…
Prudence before the announcement of a "new era" in the treatment of Alzheimer's | Science
The problem of Alzheimer's does not stop growing and threatens to "undermine social and economic…
Grifols rises nearly 10% on the stock market after the announcement of its therapy against Alzheimer's | Economy
Grifols bounced about 10% on the stock exchange on Monday after presenting the results on…
Grifols goes off in stock market after its advances against Alzheimer's | Companies
Grifols shoots on the stock market after the announcement made last Saturday on its advances…
An experimental drug manages to slow down Alzheimer's | Society
The multinational of Grifols blood products has presented this Saturday the results of a clinical…